Duality Advisers, LP Glaukos Corp Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$76.4 - $96.33 $2.82 Million - $3.55 Million	36,869 New	36,869 $3.48 Million
Q4 2022 Feb 07, 2023	BUY	$40.82 - $57.75 $521,475 - $737,756	12,775 New	12,775 $558,000
Q2 2022 Aug 08, 2022	BUY	$34.86 - $63.77 $452,064 - $826,969	12,968 New	12,968 $589,000
Q1 2022 May 09, 2022	SELL	$44.33 - $57.82 $1.47 Million - $1.92 Million	-33,220 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$40.27 - $56.99 $1.15 Million - $1.63 Million	-28,678 Reduced 46.33%	33,220 $1.48 Million
Q3 2021 Nov 08, 2021	BUY	$47.43 - $84.23 $2.94 Million - $5.21 Million	61,898 New	61,898 $2.98 Million

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.